Indaptus Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Indaptus Therapeutics

17/08/2021 19:35

* Indaptus Therapeutics Inc  INDP.OQ  reported a quarterly
adjusted loss of $3.16​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of $2.56 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Indaptus Therapeutics Inc's reported EPS for the quarter was a
loss of $5.53​.
* The mean earnings estimate of analysts had risen by
about 22.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Indaptus Therapeutics Inc shares had fallen by 41.6% this
quarter and lost 41.2% so far this year.
* The company reported a quarterly loss of $7.43 million.
* Wall Street's median 12-month price target for Indaptus
Therapeutics Inc is $52.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 17 at 06:35 p.m.  ​All
figures in US dollars unless otherwise stated